img

Global siRNA Drug Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global siRNA Drug Market Research Report 2024

The global research and development of siRNA drugs is still in the development stage of the industry. There are about 300 projects after the global laboratory stage, and the overall development trend is good. Its therapeutic areas are mainly concentrated in tumor, neurology and ophthalmology. Since siRNA has a larger molecular weight and stronger charge than ASO, it is more difficult for siRNA to enter cells by itself, so siRNA drugs have higher requirements for carriers, which is why siRNA drugs are approved later than ASO drugs big reason.
According to Mr Accuracy reports’s new survey, global siRNA Drug market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole siRNA Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global siRNA Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Genzyme
Alnylam
Dicerna
Quark Pharmaceuticals
Arrowhead
Exicure
Miragen Therapeutics
Silence
Sylentis
Avidity Biosciences
Dicerna
BioNTech
Moderna Therapeutics
The WhiteOak Group, Inc.
Segment by Type
Givlaari
Patisiran
Givosiran

Segment by Application


Single Gene Rare Disease
Protein Deposition Disease
Chronic Liver Disease
Others

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The siRNA Drug report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 siRNA Drug Market Overview
1.1 Product Overview and Scope of siRNA Drug
1.2 siRNA Drug Segment by Type
1.2.1 Global siRNA Drug Market Value Comparison by Type (2024-2034)
1.2.2 Givlaari
1.2.3 Patisiran
1.2.4 Givosiran
1.3 siRNA Drug Segment by Application
1.3.1 Global siRNA Drug Market Value by Application: (2024-2034)
1.3.2 Single Gene Rare Disease
1.3.3 Protein Deposition Disease
1.3.4 Chronic Liver Disease
1.3.5 Others
1.4 Global siRNA Drug Market Size Estimates and Forecasts
1.4.1 Global siRNA Drug Revenue 2018-2029
1.4.2 Global siRNA Drug Sales 2018-2029
1.4.3 Global siRNA Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 siRNA Drug Market Competition by Manufacturers
2.1 Global siRNA Drug Sales Market Share by Manufacturers (2018-2024)
2.2 Global siRNA Drug Revenue Market Share by Manufacturers (2018-2024)
2.3 Global siRNA Drug Average Price by Manufacturers (2018-2024)
2.4 Global siRNA Drug Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of siRNA Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of siRNA Drug, Product Type & Application
2.7 siRNA Drug Market Competitive Situation and Trends
2.7.1 siRNA Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest siRNA Drug Players Market Share by Revenue
2.7.3 Global siRNA Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 siRNA Drug Retrospective Market Scenario by Region
3.1 Global siRNA Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global siRNA Drug Global siRNA Drug Sales by Region: 2018-2029
3.2.1 Global siRNA Drug Sales by Region: 2018-2024
3.2.2 Global siRNA Drug Sales by Region: 2024-2029
3.3 Global siRNA Drug Global siRNA Drug Revenue by Region: 2018-2029
3.3.1 Global siRNA Drug Revenue by Region: 2018-2024
3.3.2 Global siRNA Drug Revenue by Region: 2024-2029
3.4 North America siRNA Drug Market Facts & Figures by Country
3.4.1 North America siRNA Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America siRNA Drug Sales by Country (2018-2029)
3.4.3 North America siRNA Drug Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe siRNA Drug Market Facts & Figures by Country
3.5.1 Europe siRNA Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe siRNA Drug Sales by Country (2018-2029)
3.5.3 Europe siRNA Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific siRNA Drug Market Facts & Figures by Country
3.6.1 Asia Pacific siRNA Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific siRNA Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific siRNA Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America siRNA Drug Market Facts & Figures by Country
3.7.1 Latin America siRNA Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America siRNA Drug Sales by Country (2018-2029)
3.7.3 Latin America siRNA Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa siRNA Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa siRNA Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa siRNA Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa siRNA Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global siRNA Drug Sales by Type (2018-2029)
4.1.1 Global siRNA Drug Sales by Type (2018-2024)
4.1.2 Global siRNA Drug Sales by Type (2024-2029)
4.1.3 Global siRNA Drug Sales Market Share by Type (2018-2029)
4.2 Global siRNA Drug Revenue by Type (2018-2029)
4.2.1 Global siRNA Drug Revenue by Type (2018-2024)
4.2.2 Global siRNA Drug Revenue by Type (2024-2029)
4.2.3 Global siRNA Drug Revenue Market Share by Type (2018-2029)
4.3 Global siRNA Drug Price by Type (2018-2029)
5 Segment by Application
5.1 Global siRNA Drug Sales by Application (2018-2029)
5.1.1 Global siRNA Drug Sales by Application (2018-2024)
5.1.2 Global siRNA Drug Sales by Application (2024-2029)
5.1.3 Global siRNA Drug Sales Market Share by Application (2018-2029)
5.2 Global siRNA Drug Revenue by Application (2018-2029)
5.2.1 Global siRNA Drug Revenue by Application (2018-2024)
5.2.2 Global siRNA Drug Revenue by Application (2024-2029)
5.2.3 Global siRNA Drug Revenue Market Share by Application (2018-2029)
5.3 Global siRNA Drug Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Genzyme
6.1.1 Genzyme Corporation Information
6.1.2 Genzyme Description and Business Overview
6.1.3 Genzyme siRNA Drug Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Genzyme siRNA Drug Product Portfolio
6.1.5 Genzyme Recent Developments/Updates
6.2 Alnylam
6.2.1 Alnylam Corporation Information
6.2.2 Alnylam Description and Business Overview
6.2.3 Alnylam siRNA Drug Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Alnylam siRNA Drug Product Portfolio
6.2.5 Alnylam Recent Developments/Updates
6.3 Dicerna
6.3.1 Dicerna Corporation Information
6.3.2 Dicerna Description and Business Overview
6.3.3 Dicerna siRNA Drug Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Dicerna siRNA Drug Product Portfolio
6.3.5 Dicerna Recent Developments/Updates
6.4 Quark Pharmaceuticals
6.4.1 Quark Pharmaceuticals Corporation Information
6.4.2 Quark Pharmaceuticals Description and Business Overview
6.4.3 Quark Pharmaceuticals siRNA Drug Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Quark Pharmaceuticals siRNA Drug Product Portfolio
6.4.5 Quark Pharmaceuticals Recent Developments/Updates
6.5 Arrowhead
6.5.1 Arrowhead Corporation Information
6.5.2 Arrowhead Description and Business Overview
6.5.3 Arrowhead siRNA Drug Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Arrowhead siRNA Drug Product Portfolio
6.5.5 Arrowhead Recent Developments/Updates
6.6 Exicure
6.6.1 Exicure Corporation Information
6.6.2 Exicure Description and Business Overview
6.6.3 Exicure siRNA Drug Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Exicure siRNA Drug Product Portfolio
6.6.5 Exicure Recent Developments/Updates
6.7 Miragen Therapeutics
6.6.1 Miragen Therapeutics Corporation Information
6.6.2 Miragen Therapeutics Description and Business Overview
6.6.3 Miragen Therapeutics siRNA Drug Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Miragen Therapeutics siRNA Drug Product Portfolio
6.7.5 Miragen Therapeutics Recent Developments/Updates
6.8 Silence
6.8.1 Silence Corporation Information
6.8.2 Silence Description and Business Overview
6.8.3 Silence siRNA Drug Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Silence siRNA Drug Product Portfolio
6.8.5 Silence Recent Developments/Updates
6.9 Sylentis
6.9.1 Sylentis Corporation Information
6.9.2 Sylentis Description and Business Overview
6.9.3 Sylentis siRNA Drug Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Sylentis siRNA Drug Product Portfolio
6.9.5 Sylentis Recent Developments/Updates
6.10 Avidity Biosciences
6.10.1 Avidity Biosciences Corporation Information
6.10.2 Avidity Biosciences Description and Business Overview
6.10.3 Avidity Biosciences siRNA Drug Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Avidity Biosciences siRNA Drug Product Portfolio
6.10.5 Avidity Biosciences Recent Developments/Updates
6.11 Dicerna
6.11.1 Dicerna Corporation Information
6.11.2 Dicerna siRNA Drug Description and Business Overview
6.11.3 Dicerna siRNA Drug Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Dicerna siRNA Drug Product Portfolio
6.11.5 Dicerna Recent Developments/Updates
6.12 BioNTech
6.12.1 BioNTech Corporation Information
6.12.2 BioNTech siRNA Drug Description and Business Overview
6.12.3 BioNTech siRNA Drug Sales, Revenue and Gross Margin (2018-2024)
6.12.4 BioNTech siRNA Drug Product Portfolio
6.12.5 BioNTech Recent Developments/Updates
6.13 Moderna Therapeutics
6.13.1 Moderna Therapeutics Corporation Information
6.13.2 Moderna Therapeutics siRNA Drug Description and Business Overview
6.13.3 Moderna Therapeutics siRNA Drug Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Moderna Therapeutics siRNA Drug Product Portfolio
6.13.5 Moderna Therapeutics Recent Developments/Updates
6.14 The WhiteOak Group, Inc.
6.14.1 The WhiteOak Group, Inc. Corporation Information
6.14.2 The WhiteOak Group, Inc. siRNA Drug Description and Business Overview
6.14.3 The WhiteOak Group, Inc. siRNA Drug Sales, Revenue and Gross Margin (2018-2024)
6.14.4 The WhiteOak Group, Inc. siRNA Drug Product Portfolio
6.14.5 The WhiteOak Group, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 siRNA Drug Industry Chain Analysis
7.2 siRNA Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 siRNA Drug Production Mode & Process
7.4 siRNA Drug Sales and Marketing
7.4.1 siRNA Drug Sales Channels
7.4.2 siRNA Drug Distributors
7.5 siRNA Drug Customers
8 siRNA Drug Market Dynamics
8.1 siRNA Drug Industry Trends
8.2 siRNA Drug Market Drivers
8.3 siRNA Drug Market Challenges
8.4 siRNA Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global siRNA Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global siRNA Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global siRNA Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global siRNA Drug Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global siRNA Drug Sales Market Share by Manufacturers (2018-2024)
Table 6. Global siRNA Drug Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global siRNA Drug Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market siRNA Drug Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of siRNA Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of siRNA Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of siRNA Drug, Product Type & Application
Table 12. Global Key Manufacturers of siRNA Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global siRNA Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in siRNA Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global siRNA Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global siRNA Drug Sales by Region (2018-2024) & (K Units)
Table 18. Global siRNA Drug Sales Market Share by Region (2018-2024)
Table 19. Global siRNA Drug Sales by Region (2024-2029) & (K Units)
Table 20. Global siRNA Drug Sales Market Share by Region (2024-2029)
Table 21. Global siRNA Drug Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global siRNA Drug Revenue Market Share by Region (2018-2024)
Table 23. Global siRNA Drug Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global siRNA Drug Revenue Market Share by Region (2024-2029)
Table 25. North America siRNA Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America siRNA Drug Sales by Country (2018-2024) & (K Units)
Table 27. North America siRNA Drug Sales by Country (2024-2029) & (K Units)
Table 28. North America siRNA Drug Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America siRNA Drug Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe siRNA Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe siRNA Drug Sales by Country (2018-2024) & (K Units)
Table 32. Europe siRNA Drug Sales by Country (2024-2029) & (K Units)
Table 33. Europe siRNA Drug Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe siRNA Drug Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific siRNA Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific siRNA Drug Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific siRNA Drug Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific siRNA Drug Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific siRNA Drug Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America siRNA Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America siRNA Drug Sales by Country (2018-2024) & (K Units)
Table 42. Latin America siRNA Drug Sales by Country (2024-2029) & (K Units)
Table 43. Latin America siRNA Drug Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America siRNA Drug Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa siRNA Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa siRNA Drug Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa siRNA Drug Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa siRNA Drug Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa siRNA Drug Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global siRNA Drug Sales (K Units) by Type (2018-2024)
Table 51. Global siRNA Drug Sales (K Units) by Type (2024-2029)
Table 52. Global siRNA Drug Sales Market Share by Type (2018-2024)
Table 53. Global siRNA Drug Sales Market Share by Type (2024-2029)
Table 54. Global siRNA Drug Revenue (US$ Million) by Type (2018-2024)
Table 55. Global siRNA Drug Revenue (US$ Million) by Type (2024-2029)
Table 56. Global siRNA Drug Revenue Market Share by Type (2018-2024)
Table 57. Global siRNA Drug Revenue Market Share by Type (2024-2029)
Table 58. Global siRNA Drug Price (US$/Unit) by Type (2018-2024)
Table 59. Global siRNA Drug Price (US$/Unit) by Type (2024-2029)
Table 60. Global siRNA Drug Sales (K Units) by Application (2018-2024)
Table 61. Global siRNA Drug Sales (K Units) by Application (2024-2029)
Table 62. Global siRNA Drug Sales Market Share by Application (2018-2024)
Table 63. Global siRNA Drug Sales Market Share by Application (2024-2029)
Table 64. Global siRNA Drug Revenue (US$ Million) by Application (2018-2024)
Table 65. Global siRNA Drug Revenue (US$ Million) by Application (2024-2029)
Table 66. Global siRNA Drug Revenue Market Share by Application (2018-2024)
Table 67. Global siRNA Drug Revenue Market Share by Application (2024-2029)
Table 68. Global siRNA Drug Price (US$/Unit) by Application (2018-2024)
Table 69. Global siRNA Drug Price (US$/Unit) by Application (2024-2029)
Table 70. Genzyme Corporation Information
Table 71. Genzyme Description and Business Overview
Table 72. Genzyme siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Genzyme siRNA Drug Product
Table 74. Genzyme Recent Developments/Updates
Table 75. Alnylam Corporation Information
Table 76. Alnylam Description and Business Overview
Table 77. Alnylam siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Alnylam siRNA Drug Product
Table 79. Alnylam Recent Developments/Updates
Table 80. Dicerna Corporation Information
Table 81. Dicerna Description and Business Overview
Table 82. Dicerna siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Dicerna siRNA Drug Product
Table 84. Dicerna Recent Developments/Updates
Table 85. Quark Pharmaceuticals Corporation Information
Table 86. Quark Pharmaceuticals Description and Business Overview
Table 87. Quark Pharmaceuticals siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Quark Pharmaceuticals siRNA Drug Product
Table 89. Quark Pharmaceuticals Recent Developments/Updates
Table 90. Arrowhead Corporation Information
Table 91. Arrowhead Description and Business Overview
Table 92. Arrowhead siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Arrowhead siRNA Drug Product
Table 94. Arrowhead Recent Developments/Updates
Table 95. Exicure Corporation Information
Table 96. Exicure Description and Business Overview
Table 97. Exicure siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Exicure siRNA Drug Product
Table 99. Exicure Recent Developments/Updates
Table 100. Miragen Therapeutics Corporation Information
Table 101. Miragen Therapeutics Description and Business Overview
Table 102. Miragen Therapeutics siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Miragen Therapeutics siRNA Drug Product
Table 104. Miragen Therapeutics Recent Developments/Updates
Table 105. Silence Corporation Information
Table 106. Silence Description and Business Overview
Table 107. Silence siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Silence siRNA Drug Product
Table 109. Silence Recent Developments/Updates
Table 110. Sylentis Corporation Information
Table 111. Sylentis Description and Business Overview
Table 112. Sylentis siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Sylentis siRNA Drug Product
Table 114. Sylentis Recent Developments/Updates
Table 115. Avidity Biosciences Corporation Information
Table 116. Avidity Biosciences Description and Business Overview
Table 117. Avidity Biosciences siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Avidity Biosciences siRNA Drug Product
Table 119. Avidity Biosciences Recent Developments/Updates
Table 120. Dicerna Corporation Information
Table 121. Dicerna Description and Business Overview
Table 122. Dicerna siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Dicerna siRNA Drug Product
Table 124. Dicerna Recent Developments/Updates
Table 125. BioNTech Corporation Information
Table 126. BioNTech Description and Business Overview
Table 127. BioNTech siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. BioNTech siRNA Drug Product
Table 129. BioNTech Recent Developments/Updates
Table 130. Moderna Therapeutics Corporation Information
Table 131. Moderna Therapeutics Description and Business Overview
Table 132. Moderna Therapeutics siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Moderna Therapeutics siRNA Drug Product
Table 134. Moderna Therapeutics Recent Developments/Updates
Table 135. The WhiteOak Group, Inc. Corporation Information
Table 136. The WhiteOak Group, Inc. Description and Business Overview
Table 137. The WhiteOak Group, Inc. siRNA Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. The WhiteOak Group, Inc. siRNA Drug Product
Table 139. The WhiteOak Group, Inc. Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. siRNA Drug Distributors List
Table 143. siRNA Drug Customers List
Table 144. siRNA Drug Market Trends
Table 145. siRNA Drug Market Drivers
Table 146. siRNA Drug Market Challenges
Table 147. siRNA Drug Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of siRNA Drug
Figure 2. Global siRNA Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global siRNA Drug Market Share by Type in 2022 & 2029
Figure 4. Givlaari Product Picture
Figure 5. Patisiran Product Picture
Figure 6. Givosiran Product Picture
Figure 7. Global siRNA Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global siRNA Drug Market Share by Application in 2022 & 2029
Figure 9. Single Gene Rare Disease
Figure 10. Protein Deposition Disease
Figure 11. Chronic Liver Disease
Figure 12. Others
Figure 13. Global siRNA Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global siRNA Drug Market Size (2018-2029) & (US$ Million)
Figure 15. Global siRNA Drug Sales (2018-2029) & (K Units)
Figure 16. Global siRNA Drug Average Price (US$/Unit) & (2018-2029)
Figure 17. siRNA Drug Report Years Considered
Figure 18. siRNA Drug Sales Share by Manufacturers in 2022
Figure 19. Global siRNA Drug Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest siRNA Drug Players: Market Share by Revenue in 2022
Figure 21. siRNA Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global siRNA Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America siRNA Drug Sales Market Share by Country (2018-2029)
Figure 24. North America siRNA Drug Revenue Market Share by Country (2018-2029)
Figure 25. United States siRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada siRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe siRNA Drug Sales Market Share by Country (2018-2029)
Figure 28. Europe siRNA Drug Revenue Market Share by Country (2018-2029)
Figure 29. Germany siRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France siRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. siRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy siRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia siRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific siRNA Drug Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific siRNA Drug Revenue Market Share by Region (2018-2029)
Figure 36. China siRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan siRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea siRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India siRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia siRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan siRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Southeast Asia siRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America siRNA Drug Sales Market Share by Country (2018-2029)
Figure 44. Latin America siRNA Drug Revenue Market Share by Country (2018-2029)
Figure 45. Mexico siRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil siRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina siRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa siRNA Drug Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa siRNA Drug Revenue Market Share by Country (2018-2029)
Figure 50. Turkey siRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia siRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE siRNA Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of siRNA Drug by Type (2018-2029)
Figure 54. Global Revenue Market Share of siRNA Drug by Type (2018-2029)
Figure 55. Global siRNA Drug Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of siRNA Drug by Application (2018-2029)
Figure 57. Global Revenue Market Share of siRNA Drug by Application (2018-2029)
Figure 58. Global siRNA Drug Price (US$/Unit) by Application (2018-2029)
Figure 59. siRNA Drug Value Chain
Figure 60. siRNA Drug Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries